News Generic drugmaker Hikma pledges $1bn in US investment With tariffs looming, Indian drugmaker Hikma has said it will spend $1bn to expand its manufacturing and R&D operations in the US by 2030.
News Sanofi pledges a $20 billion investment programme in the US Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US.
News Pharma still in waiting mode after UK-US trade agreement Hopes that the UK-US trade agreement would give some clarity on the situation for pharmaceuticals proved optimistic.
News UK trumpets a trade deal with India - but pharma isn't happy Various industries have welcomed news of a trade deal between the UK and India, but Britain's pharma sector isn't among them.
News US starts the clock ticking on pharma tariffs The US has launched a national security probe into the national security implications of importing pharmaceuticals, seen as a precursor to tariffs.
News Pharma warns EU of "exodus to US" without reform Pharma leaders have told the EU that without reforms the bloc could lose out on major capital investment programmes and R&D spending.
News Takeda's narcolepsy programme gets back on track Takeda will move quickly ahead with regulatory filings for oveporexton as a treatment for narcolepsy after a pair of phase 3 wins.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
